Skip to main content
. 2022 Mar 14;14:858162. doi: 10.3389/fnagi.2022.858162

FIGURE 2.

FIGURE 2

VAMP2 expression according to diseases (A) and according to the MCI evolution (B). Global significance: p < 0.001 (A). AD, Alzheimer’s Disease; MD, mixed dementia; CT, subject without cognitive decline; MCI, Mild Cognitive Impairment; MCI-AD, MCI individuals evolved to AD; MCI-MD, MCI individuals evolved to mixed dementia.